 - Subjects with brain metastases must have clinically controlled neurologic symptoms, defined as surgical excision andor radiation therapy followed by 21 days of stable neurologic function and no evidence of CNS disease progression as determined by CT or MRI within 21 days prior to the 1st dose of study drug; 